Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors

Abstract

The aim of this study was to assess the clinical utility of circulating preoperative Cyfra 21.1 [soluble fragment of cytokeratin (CK) 19] and galectin-3 (gal-3) in patients with thyroid tumors, to compare their serum values with tissue expression and to analyze the prognostic significance of these markers in relation to the clinical status of postsurgical… (More)
DOI: 10.1007/s00432-010-0838-3

Topics

6 Figures and Tables

Statistics

0100200201520162017
Citations per Year

Citation Velocity: 33

Averaging 33 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Ii2010SerumC2, title={Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors}, author={Tijana I{\vs}i{\'c} and Svetlana B. Savin and Dubravka S. Cvejic and Ilona Mare{\vc}ko and Svetislav B. Tati{\'c} and Marija J Havelka and Ivan Paunovic}, journal={Journal of Cancer Research and Clinical Oncology}, year={2010}, volume={136}, pages={1805-1812} }